RT @ManuelPeitsch: @Clive_Bates @UKCTAS @ProfGlantz @thetimes 3/4. Combined with the evidence of reduced exposure response to carcinogens (…
@Clive_Bates @UKCTAS @ProfGlantz @thetimes 3/4. Combined with the evidence of reduced exposure response to carcinogens (GEX of xenobiotic and AHR signaling) this paper addresses two of the three key questions formulated here https://t.co/dVJYFHl0lU.
@ColinMendelsohn @Lungfoundation @sophiescott2 @abc730 Yes, PREVENTION = the best solution to reduce the risk of LC. This means quitting, and if not, at least switch to ENDS. See an actionable framework to assess ENDS for their risk reduction potential b
RT @ManuelPeitsch: In our latest article, we propose that a mechanism-based approach represents a solid alternative to show, in a pre-marke…
RT @GizelleBaker: Proud to work with this team ... not only are we working to to make cigarettes obsolete ... but we are developing innovat…
RT @GizelleBaker: Proud to work with this team ... not only are we working to to make cigarettes obsolete ... but we are developing innovat…
RT @GizelleBaker: Proud to work with this team ... not only are we working to to make cigarettes obsolete ... but we are developing innovat…
Proud to work with this team ... not only are we working to to make cigarettes obsolete ... but we are developing innovative scientific approaches that will change the way we understand assess product risks ...
RT @ManuelPeitsch: In our latest article, we propose that a mechanism-based approach represents a solid alternative to show, in a pre-marke…
@jgitchell Afterthought: For example, in this article we describe an inference-based approach to assess the potential of a candidate MRTP to significantly reduce the risk of lung cancer. https://t.co/dVJYFHl0lU
In our latest article, we propose that a mechanism-based approach represents a solid alternative to show, in a pre-market setting, that switching to a cMRTP is likely to significantly reduce the risk of lung cancer. https://t.co/dVJYFHCBds https://t.co/rTi
Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products | SpringerLink https://t.co/PDoW1Ygv2O